GC Green Cross Medical Foundation Transfers Cytogenetic Testing Technology to Bahrain's Biolab

Strengthening Local Testing Capabilities Through Technology Transfer of Chromosome Analysis and FISH Testing

GC Green Cross Medical Foundation announced on October 16 that it has successfully completed a technology transfer project for cytogenetic testing with its diagnostic laboratory partner in Bahrain, Biolab.

Reference image. GC Green Cross Medical Foundation

This project focused on transferring 'chromosome analysis' and 'FISH' (fluorescence in situ hybridization) testing technologies to Biolab, thereby strengthening its local testing capabilities.

Since 2022, GC Green Cross Medical Foundation has conducted more than 150 outsourced chromosome analysis tests for Biolab. It is reported that Biolab requested the technology transfer to ensure stable local testing and to meet the growing demand for cytogenetic testing. Following the contract signing in March, the two companies conducted a 16-week training program from June to September, and plan to dispatch specialized personnel to Bahrain to support the setup of the testing procedures. Through this project, Biolab is expected to reduce logistics costs associated with specimen shipment and shorten testing turnaround times, thereby improving its responsiveness to patient needs.

Lee Sangkon, CEO of GC Green Cross Medical Foundation, stated, "This project is significant as it marks the first case of establishing a new business model based on technology transfer, going beyond simple overseas test outsourcing. This will serve as an important foundation for achieving business diversification in the mid to long term."

Founded in 1982, GC Green Cross Medical Foundation is the first and largest specialized referral laboratory in South Korea. Leveraging over 40 years of accumulated expertise and proprietary know-how, the foundation provides both diagnostic laboratory and pathological testing services.

This content was produced with the assistance of AI translation services.